http://www.cnr.it/ontology/cnr/individuo/prodotto/ID63093
Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. (Articolo in rivista)
- Type
- Label
- Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. (Articolo in rivista) (literal)
- Anno
- 2011-01-01T00:00:00+01:00 (literal)
- Alternative label
Steelman LS, Martelli AM, Nicoletti F, McCubrey JA (2011)
Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity.
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Steelman LS, Martelli AM, Nicoletti F, McCubrey JA (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Department of Microbiology & Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858
USA; Dipartimento di Scienze Anatomiche Umane e Fisiopatologia dellApparato Locomotore, Università di Bologna, Bologna, Italy; IGM-CNR, Sezione di Bologna, C/o IOR, Bologna, Italy; Department of Biomedical Sciences, University of Catania, Catania, Italy (literal)
- Titolo
- Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. (literal)
- Abstract
- The central dilemma in chemotherapy is to eliminate the rapidly proliferating cancer cells, while leaving the normal cells alone as much as possible. Limiting the detrimental side effects of mitotic inhibitors on normal cells could significantly enhance successful chemotherapy [1]. Mitotic inhibitors often kill normal proliferating (cycling) cells such as bone marrow cells, hair follicles, mucosal and epithelial cells [1-3]. These side effects can be severe in some cases and limit the benefits of chemotherapy as well as suppress the desirability of this type of cancer therapy by certain patients. A central question remains how we can improve on chemotherapy but reduce its detrimental side effects. (literal)
- Prodotto di
- Autore CNR
Incoming links:
- Prodotto
- Autore CNR di